President Trump’s proposed drug pricing reforms are putting pressure on early-stage discovery. To keep pace, teams must rethink how they manage risk, resources and collaboration.

Explore antibody discovery and the role of automation in transforming lab operations for enhanced research efficiency.

Discover how SRP-001, developed by Dr Hernan Bazan, aims to transform pain treatment and improve patient outcomes.

Explore the challenges in drug discovery amid political shifts and market changes affecting the pharmaceutical industry.

Explore the role of enzymes in breaking down β-1,2-glucans and advancing our understanding of carbohydrate metabolism.

SynaptixBio announces a major milestone with SB H-19642 in the upcoming clinical trial for treating H-ABC disease.

Explore the potential of CTX-09 against MDR bacteria and its effectiveness in addressing antibiotic resistance challenges.

A new study at Science Tokyo has developed patient-derived organoids to better understand and combat resistance in oesophageal squamous cell carcinoma (ESCC). “Unlike artificial models that are ...

Researchers at the University of Alabama have identified reelin, a glycoprotein known for its role in brain development, as a key regulator of neurons in the brain’s reward centre, potentially making ...

Genomics laid the foundation for precision medicine, but on its own, it offers only part of the picture. This article explores how integrated multiomics can provide the deeper biological context ...

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry imaging (MSI) is making that possible – reshaping drug development from the ...

Stanford scientists have successfully grown heart and liver organoids that include functioning blood vessels. This breakthrough overcomes a major size and maturity barrier, which could advance disease ...